Trial Profile
A Phase 2, randomized, double-masked, placebo-controlled, parallel-assignment study of topical N-Chlorotaurine (NCT) formulated with ammonium chloride administered for 10 days in patients with epidemic adenoviral keratoconjunctivitis (EKC)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2013
Price :
$35
*
At a glance
- Drugs Ammonium chloride (Primary) ; N-chlorotaurine (Primary)
- Indications Adenovirus infections; Infectious keratoconjunctivitis
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2011 New trial record